1. Kemper AR, Coeytaux R, Sanders GD, Van Mater H, Williams JW, Gray RN, et al: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis (JIA). Comparative Effectiveness Review No. 28. (Prepared by the Duke Evidence-based Practice Center under Contract No. HHSA 290 2007 10066.) Rockville, MD: Agency for Healthcare Research and Quality. [
http://www.ncbi.nlm.nih.gov/books/NBK65169/pdf/TOC.pdf
]
2. Goldmuntz EA, White PH, Goldmuntz EA, White PH: Juvenile idiopathic arthritis: a review for the pediatrician. Pediatr Rev. 2006, 27: e24-e32. 10.1542/pir.27-4-e24.
3. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997, 40: 1202-1209.
4. Singh G, Athreya BH, Fries JF, Goldsmith DP: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994, 37: 1761-1769. 10.1002/art.1780371209.
5. Agency for Healthcare Research and Quality: Methods Reference Guide for Effectiveness and Comparative Effectiveness Reviews, Version 1.0 [Draft posted Oct. 2007]. Rockville, MD: Agency for Healthcare Research and Quality, [
http://effectivehealthcare.ahrq.gov/repFiles/2007_10DraftMethodsGuide.pdf
]